Pictet Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Buy |
1,200,477
+153,462
| +15% | +$4.41M | 0.04% | 386 |
|
|
2025
Q1 | $35.1M | Buy |
1,047,015
+198,965
| +23% | +$6.67M | 0.04% | 373 |
|
|
2024
Q4 | $43.4M | Sell |
848,050
-60,099
| -7% | -$3.07M | 0.05% | 332 |
|
|
2024
Q3 | $46.4M | Buy |
908,149
+607,281
| +202% | +$31M | 0.05% | 304 |
|
|
2024
Q2 | $13.5M | Buy |
300,868
+291,501
| +3,112% | +$13.1M | 0.02% | 568 |
|
|
2024
Q1 | $438K | Buy |
9,367
+2,736
| +41% | +$128K | ﹤0.01% | 1358 |
|
|
2023
Q4 | $236K | Buy |
+6,631
| New | +$236K | ﹤0.01% | 1662 |
|